Prophylactic and Therapeutic Effect of Kynurenine for Experimental Autoimmune Encephalomyelitis (EAE) Disease.

Sundaram, Gayathri; Bessede, Alban; Gilot, David; Staats Pires, Ananda; Sherman, Larry S; Brew, Bruce J; Guillemin, Gilles J

Sundaram, Gayathri; Bessede, Alban; Gilot, David; Staats Pires, Ananda; Sherman, Larry S; Brew, Bruce J; Guillemin, Gilles J.

Afiliação

Sundaram G; Peter Duncan Neurosciences Research Unit, St Vincent's Centre for Applied Medical Research, Sydney, NSW, Australia.
Bessede A; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
Gilot D; ImmuSmol, Pessac, France.
Staats Pires A; INSERM U1242, University of Rennes I, Rennes, France.
Sherman LS; Neuroinflammation Group, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.
Brew BJ; Laboratório de Bioenergética e Estresse Oxidativo, Departamento de Bioquímica, Universidade Federal de Santa Catarina, Florianópolis, Brazil.
Guillemin GJ; Division of Neuroscience, Oregon National Primate Research Center, Beaverton, Oregon, USA.

Int J Tryptophan Res ; 15: 11786469221118657, 2022.

Article em En | MEDLINE | ID: mdl-36004319

Palavras-chave

Tryptophan; aryl-hydrocarbon receptor; immunosuppression; kynurenine; kynurenine pathway; ligand; multiple sclerosis; pro-ligand

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Int J Tryptophan Res Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google